Rating History for Checkmate Pharmaceuticals (CMPI) by BTIG

More Stocks Rated by BTIG | Latest Ratings for CMPI
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
4/20/2022 Kaveri Pohlman Downgrade Neutral
(Buy)		 N/A
(N/A)		 10.35
(10.50)		 1.45% Details